Computer-Based Therapy for Mild Cognitive Impairment
Primary Purpose
Mild Cognitive Impairment
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Computer-based training for Mild Cognitive Impairment (MCI)
Sponsored by

About this trial
This is an interventional treatment trial for Mild Cognitive Impairment focused on measuring Cognitive remediation, Cognitive impairment, computer, training
Eligibility Criteria
Inclusion Criteria: 1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function. 3)Fluency in English 4)Willing to meet the time commitment of the study - Exclusion Criteria: Clinically significant cerebrovascular disease Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -
Sites / Locations
- University of California, San Francisco
Outcomes
Primary Outcome Measures
The study investigates changes in a neuropsychological assessment battery pre-randomization
and upon the completion of training.
Secondary Outcome Measures
Early evaluations will be conducted from brain imaging; specifically, date
obtained via positron emission tomography (PET), magnetoencephalography (MEG),
electroencephalography (EEG), and functional magnetic resonance imaging (fMRI)
studies.
Full Information
NCT ID
NCT00319943
First Posted
April 27, 2006
Last Updated
April 27, 2006
Sponsor
Posit Science Corporation
Collaborators
University of California, San Francisco, University of California, Davis, Stanford University
1. Study Identification
Unique Protocol Identification Number
NCT00319943
Brief Title
Computer-Based Therapy for Mild Cognitive Impairment
Official Title
Computer-Based Therapy for Mild Cognitive Impairment
Study Type
Interventional
2. Study Status
Record Verification Date
April 2006
Overall Recruitment Status
Completed
Study Start Date
September 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Posit Science Corporation
Collaborators
University of California, San Francisco, University of California, Davis, Stanford University
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild cognitive impairment (MCI).
Detailed Description
The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and cognitive function following computer training, 2) to investigate the neurophysiological mechanisms underlying such neuropsychological improvements, and 3) to demonstrate the feasibility of using this kind of computer-based therapy in older populations.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment
Keywords
Cognitive remediation, Cognitive impairment, computer, training
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
48 (false)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Computer-based training for Mild Cognitive Impairment (MCI)
Primary Outcome Measure Information:
Title
The study investigates changes in a neuropsychological assessment battery pre-randomization
Title
and upon the completion of training.
Secondary Outcome Measure Information:
Title
Early evaluations will be conducted from brain imaging; specifically, date
Title
obtained via positron emission tomography (PET), magnetoencephalography (MEG),
Title
electroencephalography (EEG), and functional magnetic resonance imaging (fMRI)
Title
studies.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.
3)Fluency in English 4)Willing to meet the time commitment of the study
-
Exclusion Criteria:
Clinically significant cerebrovascular disease
Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joel Kramer, PsyD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
2013810
Citation
Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991 Apr;32(4):699-706.
Results Reference
background
PubMed Identifier
19812460
Citation
Barnes DE, Yaffe K, Belfor N, Jagust WJ, DeCarli C, Reed BR, Kramer JH. Computer-based cognitive training for mild cognitive impairment: results from a pilot randomized, controlled trial. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):205-10. doi: 10.1097/WAD.0b013e31819c6137.
Results Reference
derived
Learn more about this trial
Computer-Based Therapy for Mild Cognitive Impairment
We'll reach out to this number within 24 hrs